Charles River Laboratories International, Inc. (CRL) Stock Price

CRLStock

$297.64+84.49%52W

Market Cap$14.34B

P/E—

PEG Ratio0.12

Div yield—

Beta1.41

CRL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)77.73%

Price vs S&P 500 (4W)21.13%

PEG Ratio0.12

VGM Score48.55

P/CF (Annual)18.50x

Book Value / Share (Quarterly)$59.50

P/TBV (Annual)3.54x

Revenue Growth (3Y)0.33%

Cash Flow / Share (Quarterly)$7.76

Price vs S&P 500 (YTD)37.72%

Gross Margin (TTM)34.59%

Net Profit Margin (TTM)-5.96%

EPS (TTM)$-4.85

10-Day Avg Trading Volume0.94M

EPS Excl Extra (TTM)$-4.85

Revenue Growth (5Y)6.55%

EPS (Annual)$-2.91

ROI (Annual)-2.72%

Gross Margin (Annual)34.98%

Net Profit Margin (5Y Avg)6.28%

Cash / Share (Quarterly)$4.02

Revenue Growth QoQ (YoY)-2.72%

ROA (Last FY)-2.02%

Revenue Growth TTM (YoY)-0.74%

EBITD / Share (TTM)$3.45

ROE (5Y Avg)8.14%

Operating Margin (TTM)2.25%

Cash Flow / Share (Annual)$10.53

P/B Ratio4.81x

P/B Ratio (Quarterly)3.83x

Net Income / Employee (Annual)$-7,900

EV / Revenue (TTM)4.02x

Net Interest Coverage (TTM)0.22x

ROA (TTM)-3.19%

EV / EBITDA (TTM)95.45x

EPS Incl Extra (Annual)$-2.91

Current Ratio (Annual)1.29x

Quick Ratio (Quarterly)0.83x

3-Month Avg Trading Volume0.89M

52-Week Price Return84.49%

EV / Free Cash Flow (Annual)31.02x

Revenue / Employee (TTM)$218,500

Tangible BV / Share (Quarterly)$54.19

P/S Ratio (Annual)3.40x

Asset Turnover (Annual)0.56x

52-Week High$299.32

Operating Margin (5Y Avg)11.67%

EPS Excl Extra (Annual)$-2.91

CapEx CAGR (5Y)5.64%

Tangible BV CAGR (5Y)16.31%

26-Week Price Return88.97%

Quick Ratio (Annual)0.83x

13-Week Price Return87.95%

Total Debt / Equity (Annual)0.68x

Current Ratio (Quarterly)1.35x

Enterprise Value$16.08B

Revenue / Share Growth (5Y)6.99%

Asset Turnover (TTM)0.53x

Book Value / Share Growth (5Y)8.65%

Revenue / Employee (Annual)$219,400

Inventory Turnover (Annual)9.04x

Pretax Margin (Annual)-2.48%

Cash / Share (Annual)$4.34

3-Month Return Std Dev47.41%

Gross Margin (5Y Avg)36.25%

Net Income / Employee (TTM)$-13,000

EBITDA CAGR (5Y)-17.81%

EBITDA Interim CAGR (5Y)-4.64%

ROE (Last FY)-4.56%

Net Interest Coverage (Annual)-0.42x

EPS Basic Excl Extra (Annual)$-2.91

P/FCF (TTM)35.41x

Receivables Turnover (TTM)5.41x

EV / Free Cash Flow (TTM)43.39x

Total Debt / Equity (Quarterly)0.93x

EPS Incl Extra (TTM)$-4.85

Receivables Turnover (Annual)5.62x

ROI (TTM)-4.34%

P/S Ratio (TTM)3.41x

Pretax Margin (5Y Avg)8.63%

Revenue / Share (Annual)$81.01

Tangible BV / Share (Annual)$57.39

Forward P/E26.29x

Free OCF CAGR (5Y)6.41%

Price vs S&P 500 (52W)66.18%

Year-to-Date Return49.68%

5-Day Price Return6.95%

EPS Normalized (Annual)$-2.91

ROA (5Y Avg)3.18%

Net Profit Margin (Annual)-3.59%

Month-to-Date Return28.42%

Cash Flow / Share (TTM)$15.38

EBITD / Share (Annual)$4.12

Operating Margin (Annual)0.63%

LT Debt / Equity (Annual)0.67x

P/CF (TTM)23.44x

ROI (5Y Avg)4.22%

LT Debt / Equity (Quarterly)0.92x

EPS Basic Excl Extra (TTM)$-4.85

P/TBV (Quarterly)4.20x

P/B Ratio (Annual)3.16x

Inventory Turnover (TTM)8.36x

Pretax Margin (TTM)-4.59%

Book Value / Share (Annual)$64.30

Price vs S&P 500 (13W)85.16%

Beta1.41x

P/FCF (Annual)26.32x

Revenue / Share (TTM)$83.28

ROE (TTM)-7.72%

52-Week Low$144.26

vGradeD

gGradeD

mGradeA

vgmGradeC

CRL Earnings Surprise History

Q2 253.12est. 2.55

Q3 252.43est. 2.34

Q4 252.39est. 2.35

Q1 262.06est. 1.95

Q2 263.02est. 2.74

CRL Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.92

3.96

3.91

Industry Peers — R&D — Physical Sciences(16)

Symbol	Value Score	Growth Score	Momentum Score	Price
CRLCharles River Laboratories International, Inc.	D	D	A	$297.64
IQVIQVIA Holdings Inc.	D	C	A	$259.42
INCYIncyte Genomics Inc	C	A	B	$129.72
MEDPMedpace Holdings, Inc. Common Stock	F	B	A	$614.06
ICLRIcon Plc	C	C	B	$168.91
ABSIAbsci Corporation Common Stock	F	F	A	$9.63
OABIOmniAb, Inc. Common Stock	D	C	A	$4.66
NRCNRC Health Common Stock	D	D	B	$22.02
MXCTMaxCyte, Inc. Common Stock	C	D	B	$1.35
IBACIB Acquisition Corp. Common Stock	—	D	C	$10.89
ONMDOneMedNet Corp Class A Common Stock	D	C	D	$0.59
ISPCiSpecimen Inc. Common Stock	D	F	F	$1.60
BIAFbioAffinity Technologies, Inc. Common Stock	A	F	F	$5.19
BIAFWbioAffinity Technologies, Inc. Warrant	—	—	C	$0.08
NOTVInotiv, Inc. Common Stock	A	B	F	$0.01
OABIWOmniAb, Inc. Warrant	—	—	B	$0.23
ONMDWOneMedNet Corp Warrant	—	—	F	$0.03

About Charles River Laboratories International, Inc.

Charles River Laboratories is a leading provider of drug discovery and development services, operating since 1947. The company's three core segments—research models (supplying genetically characterized animal models for preclinical testing), discovery and safety assessment (early-stage drug development services), and manufacturing support (microbial solutions, in vitro testing, and biologics services)—position it as a critical partner throughout the pharmaceutical development lifecycle.